CXCL10 and diabetic cardiomyopathy: Sildenafil was also introduced as another potential therapeutic agent that coulddecrease CXCL10 production inboth protein and mRNA levels in human cardiac myocytes and further attenuate the circulating CXCL10 in diabetic cardiomyopathy patients [92].